iBio, Inc. (IBIO) Insider Trading
Over the last 6 months, 26 institutions increased and 14 reduced their position (13F).
Insider Activity
Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Jul
Aug
Oct
Nov
Jan
Mar
Context3-month price -7.9%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 19, 2026 | Stoner Elizabethdirector | Grant | 60,000 | $1.42 |
| Mar 27, 2026 | Banjak Marcofficer: Chief Legal Officer | Buy | 1,434 | $1.76 |
| Mar 27, 2026 | Banjak Marcofficer: Chief Legal Officer | Buy | 12,500 | $1.64 |
| Mar 23, 2026 | Brenner Martindirector, officer: See Remarks | Buy | 12,336 | $2.02 |
| Mar 23, 2026 | Duran Felipeofficer: Chief Financial Officer | Buy | 24,835 | $2.02 |
| Jan 30, 2026 | Brenner Martindirector, officer: See Remarks | Grant | 479,000 | $2.23 |
| Jan 30, 2026 | Duran Felipeofficer: Chief Financial Officer | Grant | 179,000 | $2.23 |
| Jan 30, 2026 | Banjak Marcofficer: Chief Legal Officer | Grant | 146,000 | $2.23 |
| Nov 24, 2025 | Sender Garydirector | Grant | 13,500 | $1.00 |
| Nov 24, 2025 | Clark William Ddirector | Grant | 13,500 | $1.00 |
| Nov 24, 2025 | Schimmelpennink Evert B.director | Grant | 13,500 | $1.00 |
| Nov 24, 2025 | Kropotova Alexandradirector | Grant | 13,500 | $1.00 |
| Nov 24, 2025 | Parada Antonio Bernardino Guimaraesdirector | Grant | 13,500 | $1.00 |
| Nov 24, 2025 | Arkowitz Daviddirector | Grant | 13,500 | $1.00 |
| Oct 22, 2025 | Duran Felipeofficer: Chief Financial Officer | Grant | 75,000 | $0.89 |
| Oct 22, 2025 | Brenner Martindirector, officer: See Remarks | Grant | 180,000 | $0.89 |
| Oct 22, 2025 | Banjak Marcofficer: Chief Legal Officer | Grant | 55,000 | $0.89 |
| Feb 24, 2025 | Brenner Martindirector, officer: See Remarks | Grant | 230,700 | $3.48 |
| Feb 24, 2025 | Duran Felipeofficer: Chief Financial Officer | Grant | 84,700 | $3.48 |
| Feb 24, 2025 | Banjak Marcofficer: Chief Legal Officer | Grant | 71,000 | $3.48 |
| Jan 13, 2025 | Parada Antonio Bernardino Guimaraesdirector | Buy | 183,823 | $2.72 |
| Jan 13, 2025 | Duran Felipeofficer: Chief Financial Officer | Buy | 9,191 | $2.72 |
| Jan 13, 2025 | Brenner Martindirector, officer: See Remarks | Buy | 9,191 | $2.72 |
| Jan 13, 2025 | Banjak Marcofficer: Chief Legal Officer | Buy | 9,191 | $2.72 |
| Jan 13, 2025 | Arkowitz Daviddirector | Buy | 18,382 | $2.72 |
| Jan 13, 2025 | Clark William Ddirector | Buy | 1,838 | $2.72 |
| Jan 13, 2025 | Sender Garydirector | Buy | 9,191 | $2.72 |
| Dec 9, 2024 | Parada Antonio Bernardino Guimaraesdirector | Grant | 12,600 | $2.45 |
| Nov 25, 2024 | Arkowitz Daviddirector | Grant | 12,600 | $2.45 |
| Nov 25, 2024 | Clark William Ddirector | Grant | 18,900 | $2.45 |
Source: IBIO SEC Form 4 filings, latest May 19, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their IBIO positions over the last 6 months (SEC Form 13F).
Increased
26
New positions
41
Reduced
14
Sold out
20
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| AFFINITY ASSET ADVISORS, LLC | Increased | 3.1M | May 14, 2026 |
| ECOR1 CAPITAL, LLC | New Position | 2.2M | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2.2M | May 15, 2026 |
| AFFINITY ASSET ADVISORS, LLC | New Position | 2.1M | Feb 13, 2026 |
| LOGOS GLOBAL MANAGEMENT LP | New Position | 2.0M | Feb 17, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | New Position | 2.0M | Feb 13, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 2.0M | May 15, 2026 |
| ECOR1 CAPITAL, LLC | Reduced | 1.6M | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | New Position | 1.5M | May 15, 2026 |
| LOGOS GLOBAL MANAGEMENT LP | Reduced | 1.3M | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 1.1M | Feb 17, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Reduced | 1.0M | May 15, 2026 |
| IKARIAN CAPITAL, LLC | Unchanged | 957K | May 15, 2026 |
| IKARIAN CAPITAL, LLC | Increased | 957K | Feb 18, 2026 |
| CITADEL ADVISORS LLC | New Position | 956K | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.